Artemisinin inhibits neutrophil and macrophage chemotaxis, cytokine production and NET release

Morad, H.O.J., Luqman, S., Pinto, L.G., Cunningham, K.P., Vilar, B., Clayton, G., Shankar-Hari, M. and McNaughton, P.A. 2022. Artemisinin inhibits neutrophil and macrophage chemotaxis, cytokine production and NET release. Scientific Reports. 12 (1), pp. 1-18. https://doi.org/10.1038/s41598-022-15214-6

TitleArtemisinin inhibits neutrophil and macrophage chemotaxis, cytokine production and NET release
TypeJournal article
AuthorsMorad, H.O.J., Luqman, S., Pinto, L.G., Cunningham, K.P., Vilar, B., Clayton, G., Shankar-Hari, M. and McNaughton, P.A.
Abstract

Immune cell chemotaxis to the sites of pathogen invasion is critical for fighting infection, but in life-threatening conditions such as sepsis and Covid-19, excess activation of the innate immune system is thought to cause a damaging invasion of immune cells into tissues and a consequent excessive release of cytokines, chemokines and neutrophil extracellular traps (NETs). In these circumstances, tempering excessive activation of the innate immune system may, paradoxically, promote recovery. Here we identify the antimalarial compound artemisinin as a potent and selective inhibitor of neutrophil and macrophage chemotaxis induced by a range of chemotactic agents. Artemisinin released calcium from intracellular stores in a similar way to thapsigargin, a known inhibitor of the Sarco/Endoplasmic Reticulum Calcium ATPase pump (SERCA), but unlike thapsigargin, artemisinin blocks only the SERCA3 isoform. Inhibition of SERCA3 by artemisinin was irreversible and was inhibited by iron chelation, suggesting iron-catalysed alkylation of a specific cysteine residue in SERCA3 as the mechanism by which artemisinin inhibits neutrophil motility. In murine infection models, artemisinin potently suppressed neutrophil invasion into both peritoneum and lung in vivo and inhibited the release of cytokines/chemokines and NETs. This work suggests that artemisinin may have value as a therapy in conditions such as sepsis and Covid-19 in which over-activation of the innate immune system causes tissue injury that can lead to death.

JournalScientific Reports
Journal citation12 (1), pp. 1-18
ISSN2045-2322
Year2022
PublisherNature Publishing Group
Publisher's version
License
CC BY 4.0
File Access Level
Open (open metadata and files)
Digital Object Identifier (DOI)https://doi.org/10.1038/s41598-022-15214-6
Web address (URL)https://www.nature.com/articles/s41598-022-15214-6
Publication dates
PublishedJun 2022

Related outputs

Rapid conjugation of antibodies to toxins to select candidates for the development of anticancer Antibody-Drug conjugates (ADcs)
Hoffmann, R.M., Mele, S., Cheung, A., Larcombe-Young, D., Bucaite, G., Sachouli, E., Zlatareva, I., Morad, H., Marlow, R., McDonnell, J.M., Figini, M., Lacy, K.E., Tutt, A.J.N., Spicer, J.F., Thurston, D.E., Karagiannis, S.N. and Crescioli, S. 2020. Rapid conjugation of antibodies to toxins to select candidates for the development of anticancer Antibody-Drug conjugates (ADcs). Scientific Reports. 10 (1), pp. 1-11. https://doi.org/10.1038/s41598-020-65860-x

O30 Natural compounds affecting neutrophil migration
Morad, H., Luqman, S. and McNaughton, P. 2017. O30 Natural compounds affecting neutrophil migration. Biochemical Pharmacology. 139 (1), p. 119. https://doi.org/10.1016/j.bcp.2017.06.095

Permalink - https://westminsterresearch.westminster.ac.uk/item/w0xwx/artemisinin-inhibits-neutrophil-and-macrophage-chemotaxis-cytokine-production-and-net-release


Share this

Usage statistics

23 total views
12 total downloads
These values cover views and downloads from WestminsterResearch and are for the period from September 2nd 2018, when this repository was created.